Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Anaesthesiologie ; 71(10): 801-810, 2022 10.
Article in German | MEDLINE | ID: mdl-35925170

ABSTRACT

Carbon monoxide poisoning is a common and potentially life-threatening intoxication, showing an interindividual variety of unspecific symptoms as well as late neurological and other sequelae. Two new German guidelines (S2k guidelines diagnosis and treatment of carbon monoxide poisoning as well as S3 guidelines oxygen therapy in the acute care of adult patients) focus on current evidence-based information on diagnostics as well as therapeutic options with considerable uncertainty remaining. This review summarizes current information and presents a flow scheme for daily practical use.


Subject(s)
Carbon Monoxide Poisoning , Hyperbaric Oxygenation , Adult , Carbon Monoxide , Carbon Monoxide Poisoning/diagnosis , Humans , Oxygen , Oxygen Inhalation Therapy
2.
World J Urol ; 40(2): 373-383, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35084545

ABSTRACT

PURPOSE: Advanced testicular germ cell tumours (GCT) generally have a good prognosis owing to their unique sensitivity towards cisplatin-based chemotherapies. However, cisplatin-resistant GCT have a poor outcome. Further studies are mandatory to better understand resistance mechanisms and develop therapeutic strategies for refractory GCTs. METHODS: Protein levels in cisplatin-resistant GCT cell lines of NTERA-2, NCCIT and 2102EP were analyzed by quantitative proteomic mass spectrometry (MS) in combination with stable isotope labelling by amino acids in cell culture (SILAC). Differentially abundant protein markers of acquired cisplatin resistance were validated by Western blotting. Comprehensive bioinformatical annotation using gene set enrichment analyses (GSEA) and STRING interaction analysis were performed to identify commonly affected pathways in cisplatin resistance and the data were compared to the GCT cohort of the 'The Cancer Genome Atlas'. RESULTS: A total of 4375 proteins were quantified by MS, 144 of which were found to be differentially abundant between isogenic resistant and sensitive cell line pairs (24 proteins for NTERA-2, 60 proteins for NCCIT, 75 proteins for 2102EP). Western blotting confirmed regulation of key resistance-associated proteins (CBS, ANXA1, LDHA, CTH, FDXR). GSEA revealed a statistically significant enrichment of DNA repair-associated proteins in all three resistant cell lines and specific additional processes for individual cell lines. CONCLUSION: High resolution MS combined with SILAC is a powerful tool and 144 significantly deregulated proteins were found in cisplatin-resistant GCT cell lines. Our study provides the largest proteomic in vitro library for cisplatin resistance in GCT, yet, enabling further studies to develop new treatment options for patients with refractory GCT.


Subject(s)
Antineoplastic Agents , Neoplasms, Germ Cell and Embryonal , Testicular Neoplasms , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Cell Line, Tumor , Cisplatin/pharmacology , Cisplatin/therapeutic use , Drug Resistance, Neoplasm , Humans , Male , Mass Spectrometry , Neoplasms, Germ Cell and Embryonal/drug therapy , Proteomics , Testicular Neoplasms/drug therapy , Testicular Neoplasms/pathology
3.
Afr J Emerg Med ; 11(1): 175-181, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33194539

ABSTRACT

INTRODUCTION: Due to the COVID-19 crisis or any other mass casualty situation it might be necessary to give artificial ventilation to many affected patients. Contrarily, the worldwide availability of emergency ventilators is still a shortage, especially in developing countries. METHODS: Modes of artificial ventilation were compared and the most safe, easy to use, and lung protecting principle was optimized to fit all requirements of both emergency ventilation and cost-effective mass production. RESULTS: The presented research results describe a simplified device for a pressure-controlled ventilation which works without electricity according to a known principle. Just pressurized gas and a patient connection is required. The device enables the control of basic ventilator parameters such as peak inspiratory pressure, positive end-expiratory pressure and the ventilation frequency. Further, the device is semiadaptive to the patient's lung stiffness and automatically maintains minute volume through frequency adjustment. The machine can be manufactured by turning, milling and drilling and needs purchased components with costs less than 100 USD. A sterilization and thus a reuse is possible. DISCUSSION: The presented development does not describe a ready-to-purchase ventilator, it rather outlines a refined working principle for emergency ventilation and its easiest methods of production with a minimum of requirements. The presented research aims on providing an open-source guideline for production of an emergency ventilator using worldwide available methods and thus should inspire local researchers to do a reverse engineering and eventually to put it into operation following country-specific regulations. For long-term ventilation exceeding emergency purposes, a monitoring of alarms for disconnection and violation of desired ventilator parameters should be established. The ventilator is limited to a fixed ratio between PIP and PEEP. Moreover, the ventilation frequency depends on two parameters, which needs some training. Nevertheless, the ventilator provides basic features to enable an emergency ventilation with minimal prerequisites.

4.
Sci Total Environ ; 747: 141295, 2020 Dec 10.
Article in English | MEDLINE | ID: mdl-32777513

ABSTRACT

Uranium mining and milling activities raise environmental concerns due to the release of radioactive and other toxic elements. Their long-term management thus requires a knowledge of past events coupled with a good understanding of the geochemical mechanisms regulating the mobility of residual radionuclides. This article presents the results on the traces of anthropic activity linked to previous uranium (U) mining activities in the vicinity of the Rophin tailings storage site (Puy de Dôme, France). Several complementary approaches were developed based on a study of the site's history and records, as well as on a radiological and chemical characterization of soil cores and a dendrochronology. Gamma survey measurements of the wetland downstream of the Rophin site revealed a level of 1050 nSv.h-1. Soil cores extracted in the wetland showed U concentrations of up to 1855 mg.kg-1, which appears to be associated with the presence of a whitish silt loam (WSL) soil layer located below an organic topsoil layer. Records, corroborated by prior aerial photographs and analyses of 137Cs and 14C activities, suggest the discharge of U mineral particles while the site was being operated. Moreover, lead isotope ratios indicate that contamination in the WSL layer can be discriminated by a larger contribution of radiogenic lead to total lead. The dendroanalysis correlate U emissions from Rophin with the site's history. Oak tree rings located downstream of the site contain uranium concentrations ten times higher than values measured on unaffected trees. Moreover, the highest U concentrations were recorded not only for the operating period, but more surprisingly for the recent site renovations as well. This integrated approach corroborates that U mineral particles were initially transported as mineral particles in Rophin's watershed and that a majority of the deposited uranium appears to have been trapped in the topsoil layer, with high organic matter content.


Subject(s)
Radiation Monitoring , Uranium , France , Mining , Soil , Uranium/analysis
5.
Nat Commun ; 11(1): 2436, 2020 May 15.
Article in English | MEDLINE | ID: mdl-32415062

ABSTRACT

Records of Alpine microseismicity are a powerful tool to study landscape-shaping processes and warn against hazardous mass movements. Unfortunately, seismic sensor coverage in Alpine regions is typically insufficient. Here we show that distributed acoustic sensing (DAS) bridges critical observational gaps of seismogenic processes in Alpine terrain. Dynamic strain measurements in a 1 km long fiber optic cable on a glacier surface produce high-quality seismograms related to glacier flow and nearby rock falls. The nearly 500 cable channels precisely locate a series of glacier stick-slip events (within 20-40 m) and reveal seismic phases from which thickness and material properties of the glacier and its bed can be derived. As seismic measurements can be acquired with fiber optic cables that are easy to transport, install and couple to the ground, our study demonstrates the potential of DAS technology for seismic monitoring of glacier dynamics and natural hazards.

6.
Oral Oncol ; 103: 104615, 2020 04.
Article in English | MEDLINE | ID: mdl-32120340

ABSTRACT

BACKGROUND AND PURPOSE: Adenoid cystic carcinomas (ACC) are characterized by high rate of local recurrence and late distant metastasis. Chromosomal changes in the evolution from primary tumors to metastatic disease of ACC have not been appointed. Here we investigated the chromosomal alterations of 53 primary tumors from ACC patients with different progressive states by shallow whole genome sequencing to identify potential new markers for metastatic spread. METHODS: Illumina paired-end libraries were generated using DNA from the primary tumor of 53 ACC patients. Fragmented DNA was end-repaired, A-tailed and multiplex sequencing adapters were ligated. Sequence data were mapped to HG19 and a copy-number analysis was conducted using the QDNAseq R package (version 1.10.0). Outliers were removed and data was smoothed by applying the circular binary segmentation algorithm implemented in the R package copynumber version 1.22.0. A modified chromosomal instability (CNI) score was used to analyze deletions and amplifications. RESULTS: Cluster analysis of the whole genome sequencing revealed that the frequency of chromosomal aberrations were increased in ACC with local recurrence and distant metastases in comparison to ACC patients with no metastatic spread. Specifically, chromosome 6 and 12 and exclusively the entire chromosome 4 showed an increased frequency of chromosomal alterations with tumor progression. CONCLUSION: Our data show a molecular evolution from primary tumors to local recurrences and distant metastases and pinpoint the critical chromosomal regions involved in this process. These regions should be in the focus of the search for therapeutic targets of progressive ACC.


Subject(s)
Carcinoma, Adenoid Cystic/genetics , Salivary Gland Neoplasms/genetics , Whole Genome Sequencing/methods , Carcinoma, Adenoid Cystic/pathology , Chromosome Aberrations , Disease Progression , Female , Humans , Male , Salivary Gland Neoplasms/pathology
7.
Am J Transplant ; 16(3): 921-9, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26613840

ABSTRACT

In order to investigate the hypothesis that the mammalian target of rapamycin inhibitor everolimus (EVR) shows anticytomegalovirus (CMV) activity in pediatric patients, we analyzed the impact of EVR-based immunosuppressive therapy on CMV replication and disease in a large cohort (n = 301) of pediatric kidney allograft recipients. The EVR cohort (n = 59), who also received low-dose cyclosporin, was compared with a control cohort (n = 242), who was administered standard-dose cyclosporin or tacrolimus and an antimetabolite, mostly mycophenolate mofetil (91.7%). Multivariate analysis revealed an 83% lower risk of CMV replication in the EVR cohort than in the control cohort (p = 0.005). In CMV high-risk (donor+/recipient-) patients (n = 88), the EVR-based regimen was associated with a significantly lower rate of CMV disease (0% vs. 14.3%, p = 0.046) than the standard regimen. In patients who had received chemoprophylaxis with (val-)ganciclovir (n = 63), the CMV-free survival rates at 1 year and 3 years posttransplant (100%) were significantly (p = 0.015) higher in the EVR cohort (n = 15) than in the control cohort (n = 48; 1 year, 75.0%; 3 years, 63.3%). Our data suggest that in pediatric patients at high risk of CMV, an EVR-based immunosuppressive regimen is associated with a lower risk of CMV disease than a standard-dose calcineurin inhibitor-based regimen.


Subject(s)
Cyclosporine/administration & dosage , Cytomegalovirus Infections/prevention & control , Everolimus/therapeutic use , Graft Rejection/prevention & control , Kidney Transplantation , Postoperative Complications , Virus Replication/drug effects , Child , Cytomegalovirus/drug effects , Cytomegalovirus Infections/virology , Female , Follow-Up Studies , Glomerular Filtration Rate , Graft Rejection/virology , Graft Survival/drug effects , Humans , Immunosuppression Therapy , Immunosuppressive Agents/therapeutic use , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/surgery , Kidney Function Tests , Male , Prognosis , Retrospective Studies , Risk Factors , Survival Rate
8.
Anaesthesist ; 64(12): 948-952, 2015 12.
Article in German | MEDLINE | ID: mdl-26481392

ABSTRACT

The technique of ultrasound-guided retrograde intubation is a less invasive procedure for airway management especially in an emergency situation with massive bleeding. This article describes a case of postoperative neck bleeding into the pharynx and neck leading to significant anatomical impairment combined with laryngeal obstruction that was successfully managed using this technique in a modified way. Anatomically non-palpable from a superficial approach, conventional cricotomy and awake tracheotomy were not possible and attempts of fiber optic intubation failed; therefore, ultrasound-guided tracheal puncture was used to advance a conventional central line guidewire towards and out of the mouth and to install orotracheal intubation via a Cook airway catheter cut in half which was advanced over the wire. All airway material remained in place in order to secure the airway until permanent tracheostomy was established along the wire entrance. Sufficient ventilation was possible with the Cook catheter and wire still in the tube. No hypoxic episodes occurred and the patient achieved full recovery.

9.
Ann Rheum Dis ; 73(1): 39-47, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24013647

ABSTRACT

OBJECTIVES: To evaluate the efficacy and safety of certolizumab pegol (CZP) after 24 weeks in RAPID-axSpA (NCT01087762), an ongoing Phase 3 trial in patients with axial spondyloarthritis (axSpA), including patients with ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA). METHODS: Patients with active axSpA were randomised 1:1:1 to placebo, CZP 200 mg every 2 weeks (Q2W) or CZP 400 mg every 4 weeks (Q4W). In total 325 patients were randomised. Primary endpoint was ASAS20 (Assessment of SpondyloArthritis international Society 20) response at week 12. Secondary outcomes included change from baseline in Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Bath Ankylosing Spondylitis Metrology Index (BASMI) linear. RESULTS: Baseline disease activity was similar between AS and nr-axSpA. At week 12, ASAS20 response rates were significantly higher in CZP 200 mg Q2W and CZP 400 mg Q4W arms versus placebo (57.7 and 63.6 vs 38.3, p≤0.004). At week 24, combined CZP arms showed significant (p<0.001) differences in change from baseline versus placebo in BASFI (-2.28 vs -0.40), BASDAI (-3.05 vs -1.05), and BASMI (-0.52 vs -0.07). Improvements were observed as early as week 1. Similar improvements were reported with CZP versus placebo in both AS and nr-axSpA subpopulations. Adverse events were reported in 70.4% vs 62.6%, and serious adverse events in 4.7% vs 4.7% of All CZP versus placebo groups. No deaths or malignancies were reported. CONCLUSIONS: CZP rapidly reduced the signs and symptoms of axSpA, with no new safety signals observed compared to the safety profile of CZP in RA. Similar improvements were observed across CZP dosing regimens, and in AS and nr-axSpA patients.


Subject(s)
Antibodies, Monoclonal, Humanized/administration & dosage , Immunoglobulin Fab Fragments/administration & dosage , Immunosuppressive Agents/administration & dosage , Polyethylene Glycols/administration & dosage , Spondylarthritis/drug therapy , Spondylitis, Ankylosing/drug therapy , Adult , Antibodies, Monoclonal, Humanized/adverse effects , Certolizumab Pegol , Double-Blind Method , Female , Humans , Immunoglobulin Fab Fragments/adverse effects , Immunosuppressive Agents/adverse effects , Male , Middle Aged , Placebos , Polyethylene Glycols/adverse effects , Spondylarthritis/diagnosis , Spondylitis, Ankylosing/diagnosis , Treatment Outcome
10.
Chirurg ; 83(11): 973-9, 2012 Nov.
Article in German | MEDLINE | ID: mdl-23108429

ABSTRACT

Necrotizing soft tissue infections are a complex pathological spectrum of symptoms and result in a significantly increased risk of mortality depending on the degree of dissemination as well as the underlying bacterial infection. Hyperbaric oxygen therapy (HBOT) can significantly improve the effectiveness of a multidisciplinary treatment concept consisting of surgical debridement, critical care and antibiotic treatment. HBOT itself assists solid wound healing by bactericidal and bacteriostatic effects and by increasing the oxygen supply up to the cellular level resulting in an optimization of oxygen-dependent metabolic processes. The efficacy of treatment in a centre of cooperating specialized departments can therefore be increased by utilizing HBOT as adjunct treatment. Nevertheless, if a HBOT facility is available, excluding HBOT is equivalent to omission of an effective therapy option to the disadvantage of patients.


Subject(s)
Hyperbaric Oxygenation , Skin Diseases, Bacterial/therapy , Soft Tissue Infections/therapy , Anti-Bacterial Agents/therapeutic use , Combined Modality Therapy , Debridement , Fasciitis, Necrotizing/mortality , Fasciitis, Necrotizing/therapy , Fournier Gangrene/mortality , Fournier Gangrene/therapy , Gas Gangrene/therapy , Humans , Necrosis , Patient Care Team , Skin Diseases, Bacterial/mortality , Soft Tissue Infections/mortality , Treatment Outcome
11.
Anaesthesist ; 57(5): 475-82, 2008 May.
Article in English | MEDLINE | ID: mdl-18351303

ABSTRACT

BACKGROUND AND OBJECTIVES: The aim of this randomized, single blind phase IIIb study was to evaluate the efficacy of 0.5% levobupivacaine versus 0.5% bupivacaine and 0.75% ropivacaine administered as epidural anesthesia and 0.125% levobupivacaine versus 0.125% bupivacaine and 0.2% ropivacaine for postoperative analgesia. The study was designed to test the equivalence of the overall profile of levobupivacaine against bupivacaine and ropivacaine. In addition, parameters of clinical safety were assessed. METHODS: A total of 88 patients undergoing hip surgery at 12 German academic hospitals were randomly assigned to 3 different treatment groups. Criteria for drug evaluation were the required epidural volume and time until onset and offset of sensory and motor block, the quality of postoperative analgesia using a pain visual analogue scale and verbal rating scale, as well as the need for rescue medication based on statistical non-inferiority testing. RESULTS: With respect to onset and offset of sensory and motor blockade, 0.5% levobupivacaine, 0.5% bupivacaine and 0.75% ropivacaine showed clinically significant equivalent profiles for all primary study endpoints. However, the levobupivacaine group showed a higher demand for intraoperative anesthesia. Postoperative analgesia request and pain scales did not differ significantly between groups, but comparatively lower total drug volumes were required in the bupivacaine group. No relevant differences between the trial groups concerning safety parameters were observed. CONCLUSIONS: The efficacy of epidural levobupivacaine for hip surgery and postoperative analgesia is equivalent and shows a comparable clinical profile to bupivacaine and 50-60% higher concentrated ropivacaine. The results of this equivalence study confirm suggestions derived from previous comparative studies.


Subject(s)
Amides , Analgesia, Epidural , Anesthesia, Epidural , Anesthetics, Local , Bupivacaine , Hip/surgery , Pain, Postoperative/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Amides/adverse effects , Amides/chemistry , Analgesia, Epidural/adverse effects , Anesthesia, Epidural/adverse effects , Anesthetics, Local/adverse effects , Anesthetics, Local/chemistry , Bupivacaine/adverse effects , Bupivacaine/chemistry , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Middle Aged , Nerve Block , Orthopedic Procedures , Pain Measurement , Pain, Postoperative/psychology , Ropivacaine , Stereoisomerism
12.
Vet Microbiol ; 62(2): 121-34, 1998 May.
Article in English | MEDLINE | ID: mdl-9695285

ABSTRACT

At least 10% of spontaneous chromosomal antibiotic resistant mutants of bacteria express a strain-dependent graded reduction of virulence; this correlates linearly with a prolonged generation time. Occasionally, these mutants are temperature sensitive or/and auxotrophe. The work described in this paper provides evidence that in such strains the resistance and the accompanying markers exist only as a functional genetic unit. In a series of transduction experiments with a pathogenic strain of Salmonella typhimurium, it was found that without exception, the resistance and the additional markers were 100% simultaneoulsy transferred. Furthermore, antibiotic-resistant Escherichia coli mutants with prolonged generation time, were isolated from faecal samples; it is thus indicated that, such innocuous mutants occur at any time in the intestine. It is concluded that concerns connecting such mutants to the possibility of resistance dissemination are unfounded; furthermore, even if transfer of resistance occurred, only attenuated strains would be disseminated.


Subject(s)
Bacterial Vaccines/genetics , Salmonella typhimurium/genetics , Transduction, Genetic , Animals , Bacterial Vaccines/pharmacology , Bacteriophage P22/chemistry , Bacteriophage P22/genetics , Biomarkers , Colony Count, Microbial , Drug Resistance, Microbial/genetics , Escherichia coli/drug effects , Escherichia coli/genetics , Escherichia coli/isolation & purification , Feces/microbiology , Mice , Mice, Inbred ICR , Nalidixic Acid/pharmacology , R Factors/genetics , R Factors/pharmacology , Rifampin/pharmacology , Salmonella typhimurium/drug effects , Salmonella typhimurium/immunology , Streptomycin/pharmacology , Vaccines, Attenuated/genetics , Vaccines, Attenuated/pharmacology
13.
J Immunol ; 138(7): 2024-33, 1987 Apr 01.
Article in English | MEDLINE | ID: mdl-2435788

ABSTRACT

The production and characterization of a rat mu,kappa monoclonal anti-mouse T cell subset antibody, B4B2, is reported in this paper. B4B2 typing of lymphoid tissues of commonly used inbred mouse strains revealed two types of reactivity patterns. They can be characterized as C57BL/6-like (B6-like) or C3H/He-like (C3H-like). Among B6-like strains, B4B2 recognizes 5 to 10% of spleen cells, 30 to 50% of bone marrow cells, and less than 2 to 3% of thymocytes. In C3H-like strains, B4B2 reacts with less than 1% of spleen cells, 2 to 8% of bone marrow cells, and less than 1% of thymocytes. B4B2 recognizes a T cell subset differentiation antigen expressed by B6-like strains but not by C3H-like strains. Typing of BXH recombinant inbred strains showed linked expression of B4B2 and the Ly-6 antigen. The expression of B4B2 antigen appears to be under codominant control as the median fluorescence distribution of B4B2+ cells in C57BL/6 was approximately twice that of (C57BL/6xC3H)F1. B4B2 was shown to react with approximately 40 to 50% of Lyt-2+ T cells and less than 1% of L3T4+ T cells. No staining of resting or activated B cells by B4B2 was detected. The ratio of B4B2+:Lyt-2+ cells was similar for resting T cells and activated T cells obtained from mitogen-stimulated cultures or mixed lymphocyte cultures. In neonatal spleen, substantially more B4B2+ than Lyt-2+ cells were found. With increasing age, however, a rapid decline in B4B2+ cells and a corresponding increase of Lyt-2+ cells was observed. By approximately 1 mo of age, the relative proportion of these subsets had reversed so that Lyt-2+ cells became more numerous than B4B2+ cells.


Subject(s)
Antibodies, Monoclonal/immunology , Antigens, Surface/immunology , T-Lymphocytes/classification , Age Factors , Animals , Antigens, Differentiation, T-Lymphocyte , Antigens, Ly/analysis , Antigens, Surface/genetics , B-Lymphocytes/immunology , Epitopes , Flow Cytometry , Gene Expression Regulation , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymphocyte Activation , Mice , Mice, Inbred Strains , Receptors, Antigen, B-Cell/analysis , Spleen/cytology , Spleen/immunology , T-Lymphocytes/immunology , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...